Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Chemistry International

The News Magazine of IUPAC

IUPAC members can access Chemistry International content by logging into www.iupac.org. Logged-in users coming from that site will be authenticated by www.degruyter.com.

See all formats and pricing
More options …
Volume 36, Issue 4


Successful Drug Discoveries

Published Online: 2014-07-17 | DOI: https://doi.org/10.1515/ci.2014.36.4.16a

The new project “Successful Drug Discoveries” is an extension of the completed project “Analogue-based Drug Discovery” affording three books published in 2006 (project 2002-051-1-700), 2010 (project 2008-013-1-700), and 2013 (project 2011-011-1-700) by Wiley-VCH. The book series focused on drug analogues. The plan of the new project is to present novel drugs that have been approved for use. This will include both pioneer drugs (first in class drugs) and drug analogues (follow on drugs) and both small molecule and biological drug discoveries in a range of therapeutic areas. This new project has a broader scope. Nevertheless, we want to preserve the structure of the completed book series.

The book will be written by 34 authors from Germany, Hungary, Japan, UK, and USA.

The editorial work of Janos Fischer (Richter Plc, Hungary) is helped by co-editors David P. Rotella (Montclair University, USA) and Roy Jefferis (University of Birmingham, UK) and the advisory board members: Klaus P. Bøgesø (Lundbeck, Denmark), Kazumi Kondo (Otsuka, Japan), John A. Lowe III (JL3Pharma LLC, USA), and Barry VL Potter (Uni. of Bath, UK).

An outline of the book content and chapters title is available on the project webpage.

For more information, contact the Task Group Chair Janos Fischer < >


About the article

Published Online: 2014-07-17

Published in Print: 2014-07-01

Citation Information: Chemistry International, Volume 36, Issue 4, Pages 16–16, ISSN (Online) 1365-2192, ISSN (Print) 0193-6484, DOI: https://doi.org/10.1515/ci.2014.36.4.16a.

Export Citation

©2014 by Walter de Gruyter GmbH & Co..Get Permission

Comments (0)

Please log in or register to comment.
Log in